Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
55,483,503
-
Shares change
-
-1,421,740
-
Total reported value, excl. options
-
$66,015,101
-
Value change
-
-$2,947,809
-
Put/Call ratio
-
80.12%
-
Number of buys
-
38
-
Number of sells
-
-58
-
Price
-
$1.19
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q3 2023
116 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q3 2023.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,483,503 shares
.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (7,167,591 shares), Avidity Partners Management LP (6,011,100 shares), ORBIMED ADVISORS LLC (5,463,000 shares), BlackRock Inc. (4,952,290 shares), Prosight Management, LP (4,770,799 shares), MILLENNIUM MANAGEMENT LLC (3,402,113 shares), VANGUARD GROUP INC (3,040,567 shares), SPHERA FUNDS MANAGEMENT LTD. (2,051,676 shares), Granahan Investment Management, LLC (1,452,558 shares), and GOLDMAN SACHS GROUP INC (1,385,006 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.